Université de Lorraine, EA 4360 APEMAC, Nancy, France.
Global Health - Health Systems and Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
J Antimicrob Chemother. 2018 Jul 1;73(7):1989-1996. doi: 10.1093/jac/dky098.
To investigate fear of legal claims and defensive behaviours among specialists in infectious diseases (ID) and clinical microbiology (CM) and to identify associated demographic and professional characteristics.
AntibioLegalMap was an international cross-sectional internet-based survey targeting specialists in ID and CM. Three variables were explored: fear of legal liability in antibiotic prescribing/advising on antibiotic prescription; defensive behaviours in antibiotic prescribing; and defensive behaviours in advising. A multivariable logistic regression analysis was performed to identify factors significantly associated with each of the three variables.
Eight hundred and thirty individuals from 74 countries participated. Only 0.4% (3/779) had any kind of condemnation for malpractice related to antibiotic prescription. Concerning the fear of liability, 21.2% (164/774) of respondents said they never worried, 45.1% (349/774) sometimes worried and 28.6% (221/774) frequently worried when prescribing/advising on antibiotic prescription. Being female, younger than or equal to 35 years and aware of previous cases of litigation were independently associated with fear. Most respondents (85.0%, 525/618) reported some defensive behaviour in antibiotic prescribing. These behaviours were independently associated with being younger than or equal to 35 years and sometimes or often worried about liability. Similarly, 76.4% (505/661) reported defensive behaviours in advising. These behaviours were associated with being sometimes or often worried about liability. The preferred measures to reduce fear and defensive behaviours were having local guidelines and sharing decisions through teamwork.
A significant proportion of specialists in ID and CM reported some form of defensive behaviour in prescribing or advising to prescribe antibiotics. Defensive medicine should be considered when implementing antibiotic stewardship programmes.
调查传染病(ID)和临床微生物学(CM)专家对法律诉讼的恐惧和防御行为,并确定相关的人口统计学和专业特征。
AntibioLegalMap 是一项针对 ID 和 CM 专家的国际横断面互联网调查。探讨了三个变量:在开抗生素处方/就抗生素处方提供建议时对法律责任的恐惧;在开抗生素处方时的防御行为;以及在提供建议时的防御行为。采用多变量逻辑回归分析确定与三个变量中的每一个变量显著相关的因素。
来自 74 个国家的 830 人参加了这项研究。只有 0.4%(3/779)的人因与抗生素处方相关的医疗事故而受到任何形式的谴责。关于对责任的恐惧,774 名受访者中有 21.2%(164/774)表示他们从不担心,45.1%(349/774)有时担心,28.6%(221/774)经常担心在开抗生素处方/提供建议时。女性、35 岁及以下和了解以前的诉讼案例与恐惧有关。大多数受访者(85.0%,525/618)报告在开抗生素处方时有一些防御行为。这些行为与 35 岁及以下、有时或经常担心责任有关。同样,76.4%(505/661)报告在提供建议时存在防御行为。这些行为与有时或经常担心责任有关。减少恐惧和防御行为的首选措施是制定当地指南和通过团队合作共享决策。
相当一部分 ID 和 CM 专家在开处方或提供建议开抗生素处方时采取了某种形式的防御行为。在实施抗生素管理计划时,应考虑防御性医疗。